TickerFactsScreenerDevelopers

HAEMONETICS CORP (HAE) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2008: $133.55M2009: $156.72M2010: $141.56M2011: $196.71M2012: $228.86M2013: $179.12M2014: $192.47M2015: $160.66M2016: $115.12M2017: $139.56M2018: $180.17M2019: $169.35M2020: $137.31M2021: $192.31M2022: $259.50M2023: $284.47M2024: $178.80M2025: $306.76M2026: $245.44M$245.44M
2008Cash & Equivalents (USD)2026
Fiscal YearCash & EquivalentsChange YoY
2026$245.44M-20.0%
2025$306.76M+71.6%
2024$178.80M-37.1%
2023$284.47M+9.6%
2022$259.50M+34.9%
2021$192.31M+40.1%
2020$137.31M-18.9%
2019$169.35M-6.0%
2018$180.17M+29.1%
2017$139.56M+21.2%
2016$115.12M-28.3%
2015$160.66M-16.5%
2014$192.47M+7.5%
2013$179.12M-21.7%
2012$228.86M+16.3%
2011$196.71M+39.0%
2010$141.56M-9.7%
2009$156.72M+17.3%
2008$133.55M—